Guideline of guidelines: PSMA PET in staging newly diagnosed intermediate-risk prostate cancer.

ABSTRACT:

Objective

To provide a comprehensive review and analysis of guidelines from various professional and medical organisations regarding the use of prostate-specific membrane antigen (PSMA) positron emission tomography (PET) as a staging scan for men with newly diagnosed intermediate-risk prostate cancer (PCa).

Materials and methods

English-language guidelines and recommendations from the following associations and societies were reviewed and critically analysed: European Association of Urology (EAU), American Urological Association (AUA), National Comprehensive Cancer Network (NCCN), National Institute for Health and Care Excellence (NICE), Canadian Urological Association (CUA), American Society for Clinical Oncology (ASCO), Society for Nuclear Medicine and Medical Imaging (SNM

SUBMITTER: Carll J 

PROVIDER: S-EPMC12522526 | biostudies-literature | 2025 Nov

REPOSITORIES: biostudies-literature